Beta amyloid and glucose intolerance not connected, study finds

07/29/2013 | MedPage Today (free registration)

A new study does not support previous evidence of a connection between glucose metabolism abnormalities and Alzheimer's disease, according to data published in JAMA Neurology. Researchers categorized participants enrolled in the Baltimore Longitudinal Study of Aging into two groups. The first cohort consisted of 197 participants who had at least two oral glucose tolerance tests during life and a brain autopsy after death, and the second consisted of 53 living participants who also underwent two or more OGTTs and PET scans using beta-amyloid tracer C-11 Pittsburgh Compound B. Findings showed no relationship between OGTT results and brain pathology.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN